JNJ-77242113, Icotrokinra, JNJ-77242113-AAC Placebo tablet
77242113CRD3001
Phase 3 small_molecule active
Quick answer
JNJ-77242113, Icotrokinra, JNJ-77242113-AAC Placebo tablet for Moderately to Severely Active Crohn's Disease is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Moderately to Severely Active Crohn's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active